Company
 
     About Us

     Management

     Advisors

     Contact Us



Technology

     APOE and Human
     Disease

     APOE and
     Inflammation

     Cognosci APOE
     Compounds

     Publications



Pipeline

     Multiple Sclerosis

     Traumatic Brain
     Injury

     Subarachnoid
     Hemorrhage

     Rheumatoid Arthritis

     Ischemic Stroke

     Sepsis

     Alzheimer’s Disease

     Parkinson’s Disease



Partnering

     Multiple Sclerosis

     Alzheimer’s Disease

     Subarachnoid
     Hemorrhage



News

     Latest News

Latest News

Cognosci Receives Funding for Advanced Testing of Lead Drug Candidate for the Treatment of Multiple Sclerosis

May 2010 Cognosci, Inc.

Cognosci Selected to Present at CED's Venture 2007 Conference

April 2007 Cognosci, Inc.

CED Announces 19 Early Stage Presenters for Venture 2007

March 2007 Council for Entrepreneurial Development

Cognosci Awarded Two Phase I SBIR Grants for Drug Development

February 2007 Cognosci, Inc.

Cognosci Receives Funding for Advanced Testing of Lead Drug Candidate for the Treatment of Multiple Sclerosis
more...

Cognosci Inc.
79 T. W. Alexander Drive
4401 Research Commons
Research Triangle Park
NC 27709
(919) 765-0028